Multiple Sclerosis treatment with Autologous Hematopoietic Stem Cell Transplantation (MS-ACT): A long-term prospective observational study in the Netherlands
Phase 4
- Conditions
- MS1000381610012303Multiple sclerosis
- Registration Number
- NL-OMON53285
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
All patients who undergo aHSCT for the treatment of RRMS in the Netherlands are
eligible to participate in this observational study.
Exclusion Criteria
The only exclusion criteria for this observational study is unwillingness to
participate or to sign informed consent.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method